Learn More
Medchemexpress LLC Perifosine | 157716-52-4 | 99.9% | C25H52NO4P | 5 MG

Supplier: Medchemexpress LLC HY509095MG
Perifosine is an oral Akt inhibitor that inhibits the proliferation of various tumor cell lines with IC50s ranging from 0.6 to 8.9 μM. It blocks cell cycle progression of head and neck squamous carcinoma cells at G1-S and G2-M phases by inducing p21WAF1, independent of p53 function. It also inhibits multiple signaling pathways in glial progenitors and can cooperate with temozolomide to arrest cell proliferation in gliomas in vivo. This product is for research use only and not sold to patients.
- Inhibits proliferation of various tumor cell lines
- Blocks cell cycle progression at G1-S and G2-M phases
- Induces p21WAF1, independent of p53 function
- Inhibits multiple signaling pathways in glial progenitors
- Can cooperate with temozolomide to arrest cell proliferation in gliomas in vivo
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.